Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study PXN110448: A Dose-response Study of XP13512, Compared With Concurrent Placebo Control and LYRICA(Pregabalin), in Subjects With Neuropathic Pain Associated Withdiabetic Peripheral Neuropathy (DPN)
Brief Summary: The purpose of this study is to determine whether gabapentin enacarbil (XP13512/GSK1838262), hereafter referred to as GEn is effective in the treatment of neuropathic pain associated with diabetic peripheral neuropathy(DPN)


Options:
A: Arm Label: Pregabain; Type: EXPERIMENTAL; Interventions: Drug: Pregabalin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Pregabain | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Placebo
B: Arm Label: DS-5565 5mg nighttime; Type: EXPERIMENTAL; Interventions: Drug: DS-5565 tablet, Drug: placebo capsule | Arm Label: DS-5565 10 mg at bedtime; Type: EXPERIMENTAL; Interventions: Drug: DS-5565 tablet, Drug: placebo capsule | Arm Label: DS-5565 15 mg at bedtime; Type: EXPERIMENTAL; Interventions: Drug: DS-5565 tablet, Drug: placebo capsule | Arm Label: DS-5565 20 mg total per day; Type: EXPERIMENTAL; Interventions: Drug: DS-5565 tablet, Drug: placebo capsule | Arm Label: DS-5565 30 mg total per day; Type: EXPERIMENTAL; Interventions: Drug: DS-5565 tablet, Drug: placebo capsule | Arm Label: Pregabalin 300 mg total per day; Type: ACTIVE_COMPARATOR; Interventions: Drug: pregabalin capsule, Drug: Placebo tablet | Intervention Type: DRUG; Name: DS-5565 tablet; Assigned to Arm(s): DS-5565 10 mg at bedtime, DS-5565 15 mg at bedtime, DS-5565 20 mg total per day, DS-5565 30 mg total per day, DS-5565 5mg nighttime | Intervention Type: DRUG; Name: pregabalin capsule; Assigned to Arm(s): Pregabalin 300 mg total per day | Intervention Type: DRUG; Name: Placebo tablet; Assigned to Arm(s): Pregabalin 300 mg total per day | Intervention Type: DRUG; Name: placebo capsule; Assigned to Arm(s): DS-5565 10 mg at bedtime, DS-5565 15 mg at bedtime, DS-5565 20 mg total per day, DS-5565 30 mg total per day, DS-5565 5mg nighttime
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: pregabalin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Pregabalin; Type: OTHER; Interventions: Drug: Pregabalin | Arm Label: GEn 1200mg/day; Type: EXPERIMENTAL; Interventions: Drug: GEn 1200mg/day | Arm Label: GEn 2400mg/day; Type: EXPERIMENTAL; Interventions: Drug: GEn 2400mg/day | Arm Label: GEn 3600mg/day; Type: EXPERIMENTAL; Interventions: Drug: GEn 3600mg/day | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: GEn 1200mg/day; Assigned to Arm(s): GEn 1200mg/day | Intervention Type: DRUG; Name: GEn 2400mg/day; Assigned to Arm(s): GEn 2400mg/day | Intervention Type: DRUG; Name: GEn 3600mg/day; Assigned to Arm(s): GEn 3600mg/day | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Pregabalin

Answer: D